Chlorozotocin: phase Ii evaluation in patients with myeloma
Cornell, C.J.; Pajak, T.F.; McIntyre, O.R.
Cancer Treatment Reports 68(4): 685-686
1984
ISSN/ISBN: 0361-5960 PMID: 6231990 Document Number: 232562
Document emailed within 1 workday
Related Documents
Scarffe, J.H.; Beaumont, A.R.; Crowther, D. 1983: Phase I-Ii evaluation of acronine in patients with multiple myeloma Cancer Treatment Reports 67(1): 93-94Lawton, J.O.; Giles, G.R.; Hall, J.; MacAdam, A.; Hall, R.; Matheson, T.; Bird, G. 1981: Phase Ii study of chlorozotocin in the treatment of advanced colorectal cancer Cancer Treatment Reports 65(1-2): 13-15
Case, D.C.; Sonneborn, H.L.; Paul, S.D.; Hiebel, J.; Boyd, M.A.; Shepp, M.A.; Dorsk, B.M.; Bonnem, E. 1986: Phase Ii study of rDNA alpha-2 interferon (INTRON A) in patients with multiple myeloma utilizing an escalating induction phase Cancer Treatment Reports 70(11): 1251-1254
Mouridsen, H.T.; Bramwell, V.H.; Lacave, J.; Metz, R.; Vendrik, C.; Hild, J.; McCreanney, J.; Sylvester, R. 1981: Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase Ii trial of the EORTC soft tissue and bone sarcoma group Cancer Treatment Reports 65(5-6): 509-511
Pasqualetti, P.; Casale, R.; Collacciani, A.; Colantonio, D. 1989: Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma Medicina 9(3): 280-282
Dingli, D.; Rajkumar, S.Vincent.; Nowakowski, G.S.; Gertz, M.A.; Dispenzieri, A.; Lacy, M.Q.; Hayman, S.; Fonseca, R.; Lust, J.A.; Kyle, R.A.; Greipp, P.R.; Witzig, T.E. 2005: Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial Haematologica 90(12): 1650-1654
Kyle, R.A.; Costa, G.; Cooper, M.R.; Ogawa, M.; Silver, R.T.; Glidewell, O.; Holland, J.F. 1973: Evaluation of aniline mustard in patients with multiple myeloma Cancer Research 33(5): 956-960
Rosen, L.S.; Gordon, D.; Kaminski, M.; Howell, A.; Belch, A.; Mackey, J.; Apffelstaedt, J.; Hussein, M.; Coleman, R.E.; Reitsma, D.J.; Seaman, J.J.; Chen, B.L.; Ambros, Y. 2001: Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial Cancer Journal 7(5): 377-387
Adam, Z.; Krahulová, M.; Spelda, S.; Vorlícek, J.; Hejlová, N.; Hájek, R.; Tomíska, M. 1995: Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma Vnitrni Lekarstvi 41(11): 767-772
Guseva, S.A.; Tishchenko, L.M.; Minchenko, Z.N. 1985: Evaluation of changes in serum proteins by polyacrylamide gel electrophoresis in patients with multiple myeloma Vrachebnoe Delo 1: 95-99
Dobrovolskij, S.B.; Pashev, A.G.; Yakimov, A.V. 1989: Evaluation de la variance du bruit en fréquence sur la base du spectre de puissance de phase - Evaluation of the frequency noise variance on the basis of the phase power spectrum Izvestia Vyssih Ucebnyh Zavedenij. Radiofizika 32(3): 301-306
Bataille, R.; Morlock, G.; Rosenberg, F.; Sany, J.; Serre, H. 1978: Evaluation of the tumor mass and its regression under treatment of multiple myeloma of the bones. Critical comments apropos of 22 patients Revue du Rhumatisme et des Maladies Osteo-Articulaires 45(1): 1-5
Pastor Rubín de Celis, E.; Ruiz Salmerón, R.J.; Aguirre Jaca, M.; Rivas Manga, M.C.; Marín Hernández, G. 1992: Immunoblastic lymphoma as expression of the final phase of IgA multiple myeloma Revista Clinica Espanola 191(5): 267-269
Goranov, S.; Hristova, I.; Pencheva, K. 1994: Nephrogenic diabetes insipidus--prodromal phase of multiple myeloma Folia Medica 36(2): 63-66
Gralla, R.J.; Sordillo, P.P.; Magill, G.B. 1978: Phase II evaluation of pyrazofurin in patients with metastatic sarcoma Cancer Treatment Reports 62(10): 1573-1574
Eagan, R.T.; Creagan, E.T.; Ingle, J.N.; Frytak, S.; Rubin, J. 1978: Phase II evaluation of maytansine in patients with metastatic lung cancer Cancer Treatment Reports 62(10): 1577-1579
Higgins, G.R.; Jamin, D.C.; Shore, N.A.; Momparler, R.; Hartman, G.; Siegel, S.E. 1985: Phase i evaluation of beta-2'-deoxythioguanosine in pediatric patients with leukemia Cancer Treatment Reports 69(6): 699-701
Currie, V.E.; Camacho, F.; Wittes, R.; Young, C. 1980: Phase Ii evaluation of vindesine in patients with advanced breast cancer Cancer Treatment Reports 64(4-5): 693-695
Kotel'nikov, V.M.; Gol'dberg, V.E.; Kozinets, G.I. 1983: Cytophotometric evaluation of the transition of cells from the G0 phase to the G1 phase of the cell cycle Biulleten' Eksperimental'noi Biologii i Meditsiny 95(4): 93-95
Liberati, A.M.; Cinieri, S.; Senatore, M.G.; Portuesi, M.G.; De Angelis, V.; Di Clemente, F.; Schippa, M.; Ferrajoli, A.; Arzano, S.; Berruto, P. 1990: Phase I-Ii trial on natural beta interferon in chemoresistant and relapsing multiple myeloma Haematologica 75(5): 436-442